What we're reading, June 30, 2016: concerns over Anthem-Cigna deal may mean the government moves to block the merger; why the price of childhood vaccines is actually too low; and saturated fats are not as bad as once thought.
The Department of Justice (DOJ) is said to be concerned that Anthem’s takeover of Cigna will reduce competition. Both companies met with a top official in the department, but the DOJ is skeptical that the 2 companies can fix the issues of concern, reported Bloomberg. The sources were people familiar with the matter who stayed anonymous because of the confidentiality of the review. The report increases the likelihood that the government will move to block the deal.
The price of vaccines for children may actually be too low. According to The New York Times’ blog The Upshot, the low cost of $2000 for all childhood vaccines is contributing to shortages. Even with vaccine prices rising as new ones come to market and the number of recommended doses increases, vaccines are still inexpensive considering the value they bring, wrote Austin Frakt, PhD.
Saturated fats may not be as bad for heart health as once thought. STAT reported that scientists are no longer looking at broad categories like saturated fat and are instead looking at the healthiness of specific foods. A study found that eating butter did not significantly change incidence of cardiovascular disease, coronary heart disease, or stroke. The study found pros and cons of eating 1 tablespoon of butter a day: doing so increased mortality risk by 1% but also lowered risk of diabetes by 4%.
Unmet Needs Remain in Secondary AML Following Treatment With HMAs
January 18th 2025The study demonstrated a poor prognosis overall for patients with acute myeloid leukemia (AML) who were previously treated with hypomethylating agents (HMAs) for myeloid neoplasms such as myelodysplastic syndromes.
Read More
High HSP60 Expression Signals Poor Prognosis, Aggressive Tumors in Ovarian Cancer
January 16th 2025High heat shock protein 60 (HSP60) expression in patients with ovarian cancer is associated with larger tumors, advanced stages, and worse survival outcomes, highlighting its potential as a prognostic biomarker.
Read More